Immunological circumvention of multiple organ metastases of multidrug resistant human small cell lung cancer cells by mouse-human chimeric anti-ganglioside GM2 antibody KM966

By Hanibuchi Masaki   Yano Seiji   Nishioka Yasuhiko   Yanagawa Hiroaki   Miki Toyokazu   Sone Saburo  

Clinical and Experimental Metastasis, Vol. 18, Iss. 5, 2000-09 ,pp. : 353-360

Springer Publishing Company

Access to resources Recommend Favorite

Phase I trial of combined treatment with ch14.18 and R24 monoclonal antibodies and interleukin-2 for patients with melanoma or sarcoma

By Choi Brian   Sondel Paul   Hank Jacquelyn   Schalch Heidi   Gan Jacek   King David   Kendra Kari   Mahvi David   Lee Li-Yin   Kim KyungMann   Albertini Mark  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 7, 2006-07 ,pp. : 761-774

Springer Publishing Company

Access to resources Recommend Favorite

Construction and expression of a human/mouse chimeric CD19 monoclonal antibody: Successful modification of a murine IgM to a chimeric IgG

By        

Experimental and Therapeutic Medicine, Vol. 7, Iss. 4, 2014-01 ,pp. : 849-854

Spandidos Publications

Access to resources Recommend Favorite

Functional inactivation of CD4+CD25 high regulatory T cells using low dose human/mouse chimeric anti-CD25 monoclonal antibody enhanced lymphokine-activated killer cells activity

By Okita Riki  

Targeted Oncology, Vol. 3, Iss. 4, 2008-10 ,pp. : 227-234

Springer Publishing Company

Access to resources Recommend Favorite

GD2 ganglioside specific antibody treatment downregulates PI3K/Akt/mTOR signaling network in human neuroblastoma cell lines

By          

International Journal of Oncology, Vol. 47, Iss. 3, 2015-01 ,pp. : 1143-1159

Spandidos Publications

Access to resources Recommend Favorite